Is Your Precision Medicine Data IQ Where it Should be?

  • Apr 19, 2019

Digital data is being generated at an astonishing clip, especially in the healthcare space. According to a November 2018 IDC report, healthcare is the fastest-growing industry datasphere that IDC evaluated. Critical and hypercritical (life-dependent) data are also growing fastest within the healthcare industry. IDC projects over 10 zettabytes (that’s 10 billion terabytes) of healthcare data by...

Read


Best Practices for Protecting Customer Data: Focus on Physical Security

  • Apr 18, 2019

Protected Health Information (PHI) is a favorite target of cybercriminals. Sold on the black market, PHI is estimated to be 10 to 20 times more valuable than a credit card record, which typically sells for $1 or $2.As stolen data continues to grow in value, criminals become more creative. It's an escalating battle that keeps data security a high-priority and an ongoing challenge. Knowledge,...

Read


Best Practices for Protecting Customer Data: Focus on Data Breach Prevention and Protocol

  • Apr 17, 2019

With a company’s average cost of suffering a data breach at approximately $3.86 million (IBM/Ponemon Report), cursory defenses are not enough. Data security needs to be part of your culture.At a recent XIFIN roundtable, Kevin Hagen, XIFIN Vice President of Information Systems, and I discussed how XIFIN protects customer data. Kevin introduced the value of stolen PHI data and best practices for...

Read


The Unsung Partnership Between IT Departments and Sales

  • Apr 10, 2019

Believe me, I get it. People who work in lab-related IT Departments just want to do their job uninterrupted, and the salespeople who work with them are always pushing for new products, services, and anything else that will provide them the upper hand to keep up in this extremely competitive healthcare services industry. While this seems like the making of an adversarial relationship, it doesn’t...

Read


Industry Collaboration Win: CMS Reviewing National Coverage Determination on Next Generation Sequencing Panels for Cancer Risk

  • Apr 9, 2019

The Centers for Medicare & Medicaid Services (CMS) has agreed to revisit the national coverage determination (NCD) on next-generation sequencing (NGS) panels to address concerns about the impact of the current policy on patients and their ability to affordably access testing for hereditary cancer risk.This is an accomplishment of industry collaboration. Laboratories, specialty groups, and...

Read


Considerations for Lab Leaders on the GAO Report Suggesting PAMA Rates May Lead to Billions in Excess Medicare Payments

  • Apr 5, 2019

The Government Accountability Office (GAO) released a report in November 2018 entitled, “Medicare Laboratory Tests Implementation of New Rates May Lead to Billions in Excess Payments.” While the report acknowledges that the Centers for Medicare and Medicaid Services (CMS) mismanaged the data collection for establishing market-based prices for lab tests under Protecting Access to Medicare Act of...

Read


Key Considerations for Lab Leaders Regarding the Eliminating Kickbacks in Recovery Act of 2018 (EKRA)

  • Apr 5, 2019

The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (SUPPORT Act) signed into law in October 2018, was intended to address the national opioid crisis. One of its accompanying bills, however, the Eliminating Kickbacks in Recovery Act of 2018 (EKRA), codified at 18 U.S.C. Section 220, has potential impact on many laboratories that...

Read


How Cancer Care is a Unique Use Case for Population Health

  • Apr 2, 2019

In her MedCity News article entitled Achieving the “Holy Grail” of population health management in cancer care, Patricia Goede, VP of Clinical Informatics at XIFIN, make the claim that the key to unlocking the value of population health in cancer care, is to gather clinical information from EHR’s, diagnostic and genomic data from labs and financial data from billing systems – the so-called “...

Read